A New Partnership in M & A in China

by Spiren 0 comments



Beijing (China), Paris (France), September 30, 2015 – SPIREN HealthCare, a strategy consulting firm specialized in Life Science industries and TONGTAI Uni-trust HealthCare Investing Co. Ltd, a Mergers & Acquisitions firm, announce a partnership today. This aims at partnering with CEO’s of Life Science companies looking for Mergers & Acquisitions and fund raising in China.

This Partnership is grounded in a rare combination of healthcare Expertise, Experience track records and exceptional Network in China with Strategic and Financial Investors.


About SPIREN HealthCare & TONGTAI Uni-trust HealthCare Investing Co. Ltd.

SPIREN HealthCare is a Strategy Consulting firm, focusing on China and HealthCare. With Medical Device, Pharmaceutical & Consumer Health industry EXPERTISE, EXPERIENCE track records in China, the team brings innovative and pragmatic solutions to help unlock our Clients’ full business potential. The company, founded in 2012 has offices in Paris, Beijing and Hong Kong. It has a broad client base ranging from mid-sized pharmaceuticals to medtech and private equity firms. To know more, please visit www.spirenhealthcare.com.

TONGTAI Uni-trust HealthCare Investing Co. Ltd is specialized in Mergers & Acquisitions, fund raising in Healthcare industry, in China. The team includes top executives from the healthcare industry, private hospitals and private equity firms. The company, headquartered in Beijing, is looking after small to mid cap investment, innovative healthcare products and services. Tongtai has recently acquired two local companies in the wound care and minimal invasive surgical operations categories. It is gradually shifting focus towards Europe for suitable M&A targets.


 SPIREN  HealthCare – Gaëtan de KERROS, Managing Partner  gdekerros@spirenhealthcare.com


Comments are closed.